wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q38285812-64FE3544-13F0-4608-A81A-55D63D2A3B6B
Q38285812-64FE3544-13F0-4608-A81A-55D63D2A3B6B
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38285812-64FE3544-13F0-4608-A81A-55D63D2A3B6B
Proprotein convertase subtilisin kexin 9 inhibitors: next generation in lipid-lowering therapy.
P2860
Q38285812-64FE3544-13F0-4608-A81A-55D63D2A3B6B
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38285812-64FE3544-13F0-4608-A81A-55D63D2A3B6B
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
93722403f5861f40128661827e65d95e35485aeb
P2860
Efficacy and safety of longer-term administration of evolocumab (AMG 145) in patients with hypercholesterolemia: 52-week results from the Open-Label Study of Long-Term Evaluation Against LDL-C (OSLER) randomized trial.